ebv-positive dlbcl, nos Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 1/2 (1)

Interventional (1)

Huiqiang Huang (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadfollicular lymphoma

I am/have/hadct scan

I am/have/hadplatelet count

I am/have/hadprothrombin time (pt)

I am/have/hadpositron emission tomography

I am/have/hadanticoagulant therapy

I am/have/hadebv-positive dlbcl, nos

I am/have/hadcreatinine clearance rate

I am/have/hadthyroid dysfunction

I am/have/hadtubal ligation

I am/have/hadneutrophil count

I am/have/haddifficulty breathing at rest

I am/have/hadlymphoma

I am/have/hadmeasurable disease

I am/have/hadblood transfusion

I am/have/hadb-cell lymphoma

I am/have/hadhigh-grade lymphoma

I am/have/hadanticoagulants

I am/have/hadpulmonary function test

I am/have/hadpulse oximetry

added new label for I am/have/had

more

I am looking for

I am looking forcamrelizumab

I am looking forcolony stimulating factor

I am looking forg-csf

I am looking foranticoagulants

I am looking forrituximab

I am looking fororal contraceptives

I am looking forapatinib

I am looking for18f-fdg

I am looking forgranulocyte colony stimulating factor

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

Camrelizumab in Combination With Apatinib in Refractory and Relapsed DLBCL

This study will evaluate the efficacy and safety of camrelizumab in combination with apatinib in in patients with relapsed or refractory diffuse large B cell lymphoma failed from second line chemotherapy.

follicular lymphoma

ct scan

camrelizumab

positron emission tomography

anticoagulant therapy

0 views
19 Feb, 2024
1 location

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2025 All rights reserved.